Crimean-Congo Hemorrhagic Fever Status in Pakistan, Its Prevention and Control Measures

Abstract

The virus that causes Crimean Congo Hemorrhagic Fever is known as the Crimean Congo Hemorrhagic Fever Virus. This disease is zoonotic, meaning that it may be transmitted from animals to humans. The infection is passed on from person to person by the bite of an infected tick. However, the transmission of infection from one human to another is also conceivable by direct contact with the blood or other bodily fluids of an individual who is diagnosed with the disease. The disease known as Crimean-Congo Hemorrhagic Fever may be diagnosed using a variety of approaches, including the enzyme linked immune sorbent assay, immunofluorescence assay, and polymerase chain reaction. Since the first case in Pakistan was recorded in 1976, the nation has been hit by many epidemics throughout the country. Treatment for the infection often consists of supportive care and oral ribavirin administration. However, only the province of Balochistan is regarded to be an endemic area, despite the fact that many cases have been recorded from other regions in Pakistan. To date, Food and Drug Administration has not given its approval for the development of a vaccine that can treat or cure the disease. However, the disease can be prevented by using acaricides to kill ticks, raising awareness among people who are at high risk, and taking appropriate precautions when treating patients.